Test Catalogue

Baby / Child Gut Health (Tiny Health) is the first gut test for babies 0-3 years old or children aged 3-18. It allows practitioners to detect gut imbalances and correct these early on.

This simple, non-invasive, gastrointestinal test detects bacterial overgrowth in the small intestine, often referred to as BOSI or SIBO. 

The Bacteriology Culture with Sensitivities test is designed to measure levels of beneficial, commensal (harmless), and pathogenic intestinal bacteria.

Calprotectin is a reliable noninvasive marker for differentiating gastrointestinal inflammation associated with Inflammatory Bowel Disease (IBD) from inflammation that may be associated with Irritable Bowel Syndrome (IBS). 

The Comprehensive Parasitology test helps detect the presence of microbial pathogens and parasites, and monitor treatment protocols used to improve digestive, absorptive, and inflammatory conditions. This is a two-day collection.

The Comprehensive Stool Analysis with Parasitology (CSAP) test is a non-invasive diagnostic assessment that allows practitioners to objectively evaluate the status of intestinal bacteria and detect the presence of microbial pathogens and parasites.

The GI Effects Microbial Ecology Profile tests for the status of intestinal bacteria, helping to identify predominate, opportunistic, and pathogenic bacteria using DNA analysis.

The GI Effects Comprehensive Profile uses cutting-edge technology to provide a detailed picture of the balance of the microbiome, including yeast, parasites, and bacteria that live in the large intestine. GIFX also gives insight into the digestive function, intestinal inflammation, and the overall health of the gut.

The Gastrointestinal Microbial Assay Plus (GI-MAP) assesses a patient’s microbiome from stool sample, with particular attention to microbes that may be disturbing normal microbial balance and contribute to perturbations in the GI flora.

The Gastrointestinal Microbial Assay Plus (GI-MAP) assesses a patient’s microbiome from stool sample, with particular attention to microbes that may be disturbing normal microbial balance and contribute to perturbations in the GI flora.

The GI360 gastrointestinal profile combines culturing with the latest DNA technology, offering a 360-degree assessment of the health and functioning of the gut. The  test assesses dysbiosis, identifies gut pathogens and measures digestion by combining genetic and biochemical assays with microscopy.

The GI360 Essentials gastrointestinal profile offers insight into the microbiome by combining culturing with the latest DNA technology. The test assesses dysbiosis and identifies gut pathogens by combining genetic and biochemical assays with microscopy.

The GI360 Microbiome gastrointestinal profile is a gut microbiota DNA analysis tool that identifies the abundance and diversity of key bacterial species that contribute to health and disease.

H. Pylori (stand alone)

IBS Smart is an ELISA blood test that measures the levels of two antibodies known to be elevated in patients with post-infectious irritable bowel syndrome (IBS).